Medicortex Finland Plc appointing new members for the Board of Directors

Medicortex is an innovative clinical stage biotechnology company focusing on development of diagnostics and therapy for brain injuries. Company’s short-term focus is to complete development of a rapid urine test, company’s lead product ProbTBI^TM kit for detection of biomarkers of mild traumatic brain injury, followed by prototype production and clinical evaluation. Mr. Grönberg and Mr. Ranta-Panula will be part of the enterprise to move the company forward to bring its breakthrough products to the clinics to address a significant unmet medical need.

Mr. Grönberg has over 30 years of experience in leadership. He has held executive positions in several bigger and smaller foundations and companies in Finland. In addition to leadership, Grönberg has expertise in sales management, investing, and fundraising.

Mr. Ranta-Panula has MBA education and M.Sc. degree in Drug Development from University of Turku and his current position is Chief Commercial Officer at CRST Oy. Ranta-Panula is an experienced and globally networked drug and business development professional. He holds a Certified Board Member certificate and is a board member of Turun Hallituspartnerit ry, an association of Board Professionals. Ranta-Panula has expertise in budgeting, business strategy, clinical trials, and sales.

“Medicortex is honoured to have two experienced business professionals to join the Board of Directors. We believe that we have assembled a multiskilled accountable team for the company", says Dr. Adrian Harel, CEO of Medicortex. “The broad potential of our TBI technology pipeline combined with the supplemented outstanding team of professionals marks a major step forward in advancing Medicortex to the leading technology company in the field of noninvasive testing of head injury and beyond”, Dr. Harel adds. 

Mrs. Anna Tenstam and Dr. Adrian Harel were re-elected in the Board of Directors in the Annual General Meeting of the company.

Forward-looking statements

Certain statements in this communication are forward-looking statements. They are based on the views of the company’s management, as well as the understanding and assumptions of the company’s management based on the information available at present, and due to this, they may be forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors, which may result in that the company’s actual future results, operations, achievements and performance of the sector may differ significantly from the expectations casted in these statements. Forward-looking statements are not a guarantee of the company’s operational or financial performance in the future.